Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
25/02/2025 | 13:00 | PR Newswire (US) | Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 | NYSE:FMS | Fresenius Medical Care AG |
24/02/2025 | 14:00 | PR Newswire (US) | Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics | NYSE:FMS | Fresenius Medical Care AG |
23/12/2024 | 15:00 | PR Newswire (US) | Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index | NYSE:FMS | Fresenius Medical Care AG |
20/12/2024 | 17:23 | PR Newswire (US) | Fresenius Medical Care returns to Dax 40 Index | NYSE:FMS | Fresenius Medical Care AG |
19/11/2024 | 15:00 | PR Newswire (US) | Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO System | NYSE:FMS | Fresenius Medical Care AG |
05/11/2024 | 16:32 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NYSE:FMS | Fresenius Medical Care AG |
05/11/2024 | 13:00 | PR Newswire (US) | Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024 | NYSE:FMS | Fresenius Medical Care AG |
21/10/2024 | 17:04 | PR Newswire (US) | Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024 | NYSE:FMS | Fresenius Medical Care AG |
04/09/2024 | 14:00 | PR Newswire (US) | Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software | NYSE:FMS | Fresenius Medical Care AG |
30/07/2024 | 13:00 | PR Newswire (US) | Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 | NYSE:FMS | Fresenius Medical Care AG |
12/06/2024 | 14:00 | PR Newswire (US) | Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations | NYSE:FMS | Fresenius Medical Care AG |
23/05/2024 | 18:33 | PR Newswire (US) | Moody's and S&P change Fresenius Medical Care's rating outlook to stable | NYSE:FMS | Fresenius Medical Care AG |
21/05/2024 | 16:00 | PR Newswire (US) | Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024 | NYSE:FMS | Fresenius Medical Care AG |
16/05/2024 | 15:55 | PR Newswire (US) | Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets | NYSE:FMS | Fresenius Medical Care AG |
07/05/2024 | 13:00 | PR Newswire (US) | Fresenius Medical Care starts the year with strong earnings growth | NYSE:FMS | Fresenius Medical Care AG |
22/03/2024 | 13:00 | PR Newswire (US) | Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care | NYSE:FMS | Fresenius Medical Care AG |
19/03/2024 | 13:00 | PR Newswire (US) | Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device | NYSE:FMS | Fresenius Medical Care AG |
13/03/2024 | 15:00 | PR Newswire (US) | Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources | NYSE:FMS | Fresenius Medical Care AG |
05/03/2024 | 16:10 | PR Newswire (US) | Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador | NYSE:FMS | Fresenius Medical Care AG |
20/02/2024 | 16:22 | Edgar (US Regulatory) | Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). | NYSE:FMS | Fresenius Medical Care AG |
20/02/2024 | 16:02 | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | NYSE:FMS | Fresenius Medical Care AG |
20/02/2024 | 13:30 | PR Newswire (US) | Fresenius Medical Care delivers on commitments in a year of fundamental transformation | NYSE:FMS | Fresenius Medical Care AG |
08/02/2024 | 14:54 | PR Newswire (US) | Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies | NYSE:FMS | Fresenius Medical Care AG |
05/02/2024 | 14:57 | PR Newswire (US) | Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board | NYSE:FMS | Fresenius Medical Care AG |
30/01/2024 | 12:00 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NYSE:FMS | Fresenius Medical Care AG |
08/01/2024 | 14:16 | PR Newswire (US) | Fresenius Medical Care Executes on Its Strategic Portfolio Optimization Program and Announces Key Transactions | NYSE:FMS | Fresenius Medical Care AG |
08/12/2023 | 12:23 | IH Market News | Apple Boosts Vietnam Production, Broadcom Revenue Miss, Stellantis Job Cuts – Latest Updates | NYSE:FMS | Fresenius Medical Care AG |
30/11/2023 | 13:00 | PR Newswire (US) | Fresenius Medical Care completes change of legal form into a German stock corporation | NYSE:FMS | Fresenius Medical Care AG |
21/11/2023 | 22:07 | PR Newswire (US) | Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million - 2023 earnings outlook raised | NYSE:FMS | Fresenius Medical Care AG |
01/11/2023 | 22:33 | PR Newswire (US) | Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter | NYSE:FMS | Fresenius Medical Care AG |